Search bioRxiv⌕ Search

Biology subjects

Klughammer, J.

Publications and source records attributed to Klughammer, J..

16 recordsLinked to original sources

An explanatory benchmark of spatial domain detection reveals key drivers of method performance

The spatial organization of cells within tissues is critical for understanding biological function and disease, and spatial transcriptomics enables genome-wide mapping of this organization. Numerous computational methods aim to identify spatial domains, yet their performance is often evaluated on limited datasets, leading to conflicting conclusions. Here, we present an explanatory benchmark of 26 spatial domain detection methods across 63 tissue sections from six spatial transcriptomics technologies, supplemented by over 1,000 semi-synthetic datasets that systematically vary resolution, gene panel size, and tissue architecture. By jointly analyzing real and semi-synthetic data across this broad parameter space, our benchmark uncovers systematic performance differences and sources of variability that are obscured in standard evaluations. Although most spatial methods outperform non-spatial baselines, their performance depends strongly on data resolution and cellular heterogeneity. To enable systematic analysis beyond individual methods, we introduce a modular, plug-and-play benchmarking framework that facilitates method refinement and component exchange. Using this framework, an ablation study of neural network-based approaches shows that the choice of preprocessing and clustering often has a larger impact on performance than ar-chitectural novelty alone. Together, these results provide a principled foundation for informed method selection and offer guidance for the development of robust and scalable spatial domain detection tools as spatial transcriptomics technologies continue to advance.

bioinformatics↗

scDynOmics: An Optimized Transformer Model for Representation Learning from Single-Cell Multiomics

As foundation models have become increasingly prevalent in several fields for multiple purposes, pretraining models with single-cell transcriptomic data has gained significant interest. Although existing single-cell foundation models have demonstrated that transformer-based designs can be applied to various biological tasks, they do not show consistently competitive performance compared to much simpler approaches while requiring much more resources in terms of data and compute. Here, we introduce scDynOmics, a pretrainable multiomics-capable transformer for representation learning from single-cell data. The model is motivated by gene regulatory networks without excluding unknown interactions between genes and adopts a Linformer-style attention mechanism to scale to coding-genome wide multimodal inputs. Pretraining on paired single-cell transcriptomic and chromatin accessibility profiles yields compact high-fidelity embeddings that represent cellular states and developmental dynamics. For versatile application, scDynOmics employs low-rank adaptation modules, enabling parameter-efficient fine-tuning for downstream tasks. We demonstrate that scDynOmics outperforms existing single-cell foundation models by a large margin and achieves or surpasses state-of-the-art performance compared to simpler approaches, while revealing interpretable factors driving developmental trajectories and perturbation responses that simpler approaches cannot provide. Overall, scDynOmics is an efficient, scalable, flexible, and interpretable framework for cellular representation learning and deciphering cellular heterogeneity and dynamics.

bioinformatics↗

Truncating RELA variants drive autoinflammation and autoimmunity by impairing the negative feedback control of NF-kB

The NF-{kappa}B signaling pathway coordinates inflammation, cell survival, and proliferation, while restraining excessive cell death to maintain immune homeostasis. Truncating mutations in RELA, encoding the NF-{kappa}B subunit p65, have been linked to autoinflammation and autoimmunity, but the underlying mechanisms remain incompletely defined. We investigated six patients from five unrelated families carrying novel heterozygous truncating RELA variants. Despite reduced p65 expression, patients exhibited a broad spectrum of inflammatory manifestations alongside elevated baseline and stimulus-induced pro-inflammatory cytokines. Functional analyses in patient-derived cells and mutant RELA knock-in models showed that upstream NF-{kappa}B signaling was intact, but induction of inhibitory regulators such as I{kappa}B and A20 was impaired. This defective feedback control shifted immune homeostasis toward amplified inflammatory responses that depended on the residual activity of the remaining functional RELA allele. Single-cell transcriptomics revealed distinct cell type-specific consequences: monocytes displayed constitutive type I interferon and NF-{kappa}B activation, B cells retained partial compensatory signaling, whereas T and NK cells exhibited transcriptional signatures of cell death pathways. Patient fibroblasts and mutant RELA knock-in cells further confirmed enhanced TNF-induced inflammatory gene expression and hypersensitivity to apoptosis and necroptosis. These findings establish RELA haploinsufficiency as a cause of systemic immune dysregulation, and link defective NF-{kappa}B feedback control to unchecked inflammation and inflammatory cell death. Graphical abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=152 SRC="FIGDIR/small/687461v1_ufig1.gif" ALT="Figure 1"> View larger version (48K): org.highwire.dtl.DTLVardef@1f0bfe6org.highwire.dtl.DTLVardef@c6cb60org.highwire.dtl.DTLVardef@1522accorg.highwire.dtl.DTLVardef@177c724_HPS_FORMAT_FIGEXP M_FIG C_FIG

immunology↗

Sample-multiplexed FACS-preprocessing of PBMCs enables scalable scRNA-seq without compromising transcriptomic or cellular integrity

Efficient preprocessing of peripheral blood mononuclear cells (PBMCs) for single-cell RNA-Sequencing (scRNA-seq) is crucial to ensure high sample throughput while maintaining sample integrity. In particular, when enrichment of rare immune cell populations is necessary to enable their representative profiling among more common PBMCs, sample preprocessing may become a detrimental bottleneck. Here, we present an optimized fluorescence-activated cell sorting (FACS)-based preprocessing workflow designed to enrich rare immune cells while conserving overall PBMC composition. The protocol integrates dead cell removal, targeted rare cell enrichment, channel splitting, and hash-based sample multiplexing together with a new powerful yet lightweight demultiplexing tool (YAHD), improving throughput and cell yield, reducing batch effects, and preserving biological context. Validation across cryopreserved human PBMCs obtained from different scientifically relevant sources (clinical routine and laboratory setting) demonstrated improved sample viability and representation of rare subsets in the final scRNA-seq data. Thorough transcriptomic assessment confirmed non-concerning levels of stress induction and T cell activation as well as low technical variability, removing concerns around FACS-processing, cross-donor multiplexing and channel splitting. The presented approach enables scalable and biologically faithful PBMC preprocessing for scRNA-seq, advancing the study of immune heterogeneity in health and disease.

genomics↗

Inference of single cell profiles from histology stains with the Single-Cell omics from Histology Analysis Framework (SCHAF)

Tissue biology involves an intricate balance between cell-intrinsic processes and interactions between cells organized in specific spatial patterns, which can be respectively captured by single cell profiling methods, such as single cell RNA-seq (scRNA-seq) and spatial transcriptomics, and histology imaging data, such as Hematoxylin-and-Eosin (H&E) stains. While single cell profiles provide rich molecular information, they can be challenging to collect routinely in the clinic and either lack spatial resolution or high gene throughput. Conversely, histological H&E assays have been a cornerstone of tissue pathology for decades, but do not directly report on molecular details, although the observed structure they capture arises from molecules and cells. Here, we leverage vision transformers and adversarial deep learning to develop the Single Cell omics from Histology Analysis Framework (SCHAF), which generates a tissue samples spatially-resolved whole transcriptome single cell omics dataset from its H&E histology image. We demonstrate SCHAF on a variety of tissues-- including lung cancer, metastatic breast cancer, placentae, and whole mouse pups--training with matched samples analyzed by sc/snRNA-seq, H&E staining, and, when available, spatial transcriptomics. SCHAF generated appropriate single cell profiles from histology images in test data, related them spatially, and compared well to ground-truth scRNA-Seq, expert pathologist annotations, or direct spatial transcriptomic measurements, with some limitations. SCHAF opens the way to next-generation H&E analyses and an integrated understanding of cell and tissue biology in health and disease.

bioinformatics↗

SlideCNA: Spatial copy number alteration detection from Slide-seq-like spatial transcriptomics data

Solid tumors are spatially heterogeneous in their genetic, molecular and cellular composition, and this variation can be meaningful for diagnosis, prognosis and therapy. Recent spatial profiling studies have mostly charted genetic and RNA variation in tumors separately. To leverage the potential of RNA to identify copy number alterations (CNAs), we developed SlideCNA, a computational tool to extract sparse spatial CNA signals from spatial transcriptomics data, using expression-aware spatial binning. We test SlideCNA on simulated and real Slide-seq data of metastatic breast cancer (MBC) and demonstrate its potential for spatial sub-clone detection.

bioinformatics↗

TACCO: Unified annotation transfer and decomposition of cell identities for single-cell and spatial omics

Rapid advances in single-cell-, spatial-, and multi-omics, allow us to profile cellular ecosystems in tissues at unprecedented resolution, scale, and depth. However, both technical limitations, such as low spatial resolution and biological variations, such as continuous spectra of cell states, often render these data imperfect representations of cellular systems, best captured as continuous mixtures over cells or molecules. Based on this conceptual insight, we build a versatile framework, TACCO (Transfer of Annotations to Cells and their COmbinations) that extends an Optimal Transport-based core by different wrappers or boosters to annotate a wide variety of data. We apply TACCO to identify cell types and states, decipher spatio-molecular tissue structure at the cell and molecular level, and resolve differentiation trajectories. TACCO excels in speed, scalability, and adaptability, while successfully outperforming benchmarks across diverse synthetic and biological datasets. Along with highly optimized visualization and analysis functions, TACCO forms a comprehensive integrated framework for studies of high-dimensional, high-resolution biology.

bioinformatics↗

Integrative single cell and spatial transcriptomics of colorectal cancer reveals multicellular functional units that support tumor progression

While advances in single cell genomics have helped to chart the cellular components of tumor ecosystems, it has been more challenging to characterize their specific spatial organization and functional interactions. Here, we combine single cell RNA-seq, spatial transcriptomics by Slide-seq, and in situ multiplex RNA analysis, to create a detailed spatial map of healthy and dysplastic colon cellular ecosystems and their association with disease progression. We profiled inducible genetic CRC mouse models that recapitulate key features of human CRC, assigned cell types and epithelial expression programs to spatial tissue locations in tumors, and computationally used them to identify the regional features spanning different cells in the same spatial niche. We find that tumors were organized in cellular neighborhoods, each with a distinct composition of cell subtypes, expression programs, and local cellular interactions. Comparing to scRNA-seq and Slide-seq data from human CRC, we find that both cell composition and layout features were conserved between the species, with mouse neighborhoods correlating with malignancy and clinical outcome in human patient tumors, highlighting the relevance of our findings to human disease. Our work offers a comprehensive framework that is applicable across various tissues, tumors, and disease conditions, with tools for the extrapolation of findings from experimental mouse models to human diseases.

cancer biology↗

Comparative analysis of genome-scale, base-resolution DNA methylation profiles across 580 animal species

Methylation of cytosines is the prototypic epigenetic modification of the DNA. It has been implicated in various regulatory mechanisms throughout the animal kingdom and particularly in vertebrates. We mapped DNA methylation in 580 animal species (535 vertebrates, 45 invertebrates), resulting in 2443 genome-scale, base-resolution DNA methylation profiles of primary tissue samples from various organs. Reference-genome independent analysis of this comprehensive dataset quantified the association of DNA methylation with the underlying genomic DNA sequence throughout vertebrate evolution. We observed a broadly conserved link with two major transitions - once in the first vertebrates and again with the emergence of reptiles. Cross-species comparisons focusing on individual organs supported a deeply conserved association of DNA methylation with tissue type, and cross-mapping analysis of DNA methylation at gene promoters revealed evolutionary changes for orthologous genes with conserved DNA methylation patterns. In summary, this study establishes a large resource of vertebrate and invertebrate DNA methylomes, it showcases the power of reference-free epigenome analysis in species for which no reference genomes are available, and it contributes an epigenetic perspective to the study of vertebrate evolution.

genomics↗

SM-Omics: An automated platform for high-throughput spatial multi-omics

The spatial organization of cells and molecules plays a key role in tissue function in homeostasis and disease. Spatial Transcriptomics (ST) has recently emerged as a key technique to capture and positionally barcode RNAs directly in tissues. Here, we advance the application of ST at scale, by presenting Spatial Multiomics (SM-Omics) as a fully automated high-throughput platform for combined and spatially resolved transcriptomics and antibody-based proteomics.

genomics↗

Expansion Sequencing: Spatially Precise In Situ Transcriptomics in Intact Biological Systems

AbstractMethods for highly multiplexed RNA imaging are limited in spatial resolution, and thus in their ability to localize transcripts to nanoscale and subcellular compartments. We adapt expansion microscopy, which physically expands biological specimens, for long-read untargeted and targeted in situ RNA sequencing. We applied untargeted expansion sequencing (ExSeq) to mouse brain, yielding readout of thousands of genes, including splice variants and novel transcripts. Targeted ExSeq yielded nanoscale-resolution maps of RNAs throughout dendrites and spines in neurons of the mouse hippocampus, revealing patterns across multiple cell types; layer-specific cell types across mouse visual cortex; and the organization and position-dependent states of tumor and immune cells in a human metastatic breast cancer biopsy. Thus ExSeq enables highly multiplexed mapping of RNAs, from nanoscale to system scale. One Sentence SummaryIn situ sequencing of physically expanded specimens enables multiplexed mapping of RNAs at nanoscale, subcellular resolution.

genomics↗

A single-cell and single-nucleus RNA-seq toolbox for fresh and frozen human tumors

Single cell genomics is essential to chart the complex tumor ecosystem. While single cell RNA-Seq (scRNA-Seq) profiles RNA from cells dissociated from fresh tumor tissues, single nucleus RNA-Seq (snRNA-Seq) is needed to profile frozen or hard-to-dissociate tumors. Each strategy requires modifications to fit the unique characteristics of different tissue and tumor types, posing a barrier to adoption. Here, we developed a systematic toolbox for profiling fresh and frozen clinical tumor samples using scRNA-Seq and snRNA-Seq, respectively. We tested eight tumor types of varying tissue and sample characteristics (resection, biopsy, ascites, and orthotopic patient-derived xenograft): lung cancer, metastatic breast cancer, ovarian cancer, melanoma, neuroblastoma, pediatric sarcoma, glioblastoma, pediatric high-grade glioma, and chronic lymphocytic leukemia. Analyzing 212,498 cells and nuclei from 39 clinical samples, we evaluated protocols by cell quality, recovery rate, and cellular composition. We optimized protocols for fresh tissue dissociation for different tumor types using a decision tree to account for the technical and biological variation between clinical samples. We established methods for nucleus isolation from OCT embedded and fresh-frozen tissues, with an optimization matrix varying mechanical force, buffer, and detergent. scRNA-Seq and snRNA-Seq from matched samples recovered the same cell types and intrinsic expression profiles, but at different proportions. Our work provides direct guidance across a broad range of tumors, including criteria for testing and selecting methods from the toolbox for other tumors, thus paving the way for charting tumor atlases.

genomics↗

High-density spatial transcriptomics arrays for in situ tissue profiling

Tissue function relies on the precise spatial organization of cells characterized by distinct molecular profiles. Single-cell RNA-Seq captures molecular profiles but not spatial organization. Conversely, spatial profiling assays either lack global transcriptome information or are not at the single-cell level. Here, we develop High-Density Spatial Transcriptomics (HDST), a method for RNA-seq at high spatial resolution. Spatially barcoded reverse transcription oligonucleotides are coupled to beads that are then randomly deposited in individual wells on a slide. The barcoded beads are decoded and coupled to a specific spatial address. We then capture and spatially in situ label RNA from the same histological tissue sections placed on the bead array slide. HDST recovers hundreds of thousands of transcript-coupled barcodes per experiment at 2 m resolution. We demonstrate HDST in the mouse brain, use it to resolve spatial expression patterns and cell types, and show how to combine it with histological stains to relate expression patterns to tissue architecture and anatomy. HDST opens the way to 2D spatial analysis of tissues at high resolution.

genomics↗

The ERBB-STAT3 Axis Drives Tasmanian Devil Facial Tumor Disease

The marsupial Tasmanian devil (Sarcophilus harrisii) faces extinction due to transmissible devil facial tumor disease (DFTD). To unveil the molecular underpinnings of DFTD, we designed an approach that combines sensitivity to drugs with an integrated systems-biology characterization. Sensitivity to inhibitors of the ERBB family of receptor tyrosine kinases correlated with their overexpression, suggesting a causative link. Proteomic and DNA methylation analyses revealed tumor-specific signatures linked to oncogenic signaling hubs including evolutionary conserved STAT3. Indeed, ERBB inhibition blocked phosphorylation of STAT3 and arrested cancer cells. Pharmacological blockade of ERBB signaling prevented tumor growth in a xenograft model and resulted in recovery of MHC class I gene expression. This link between the hyperactive ERBB-STAT3 axis and MHC class I mediated tumor immunosurveillance provides mechanistic insights into horizontal transmissibility and led us to the proposition of a dual chemo-immunotherapeutic strategy to save Tasmanian devils from DFTD.

cancer biology↗

The DNA methylation landscape of glioblastoma disease progression shows extensive heterogeneity in time and space

Glioblastoma is characterized by widespread genetic and transcriptional heterogeneity, yet little is known about the role of the epigenome in glioblastoma disease progression. Here, we present genome-scale maps of the DNA methylation dynamics in matched primary and recurring glioblastoma tumors, based on a national population registry and a comprehensively annotated clinical cohort. We demonstrate the feasibility of DNA methylation mapping in a large set of routinely collected formalin-fixed paraffin-embedded (FFPE) samples, and we validate bisulfite sequencing as a multi-purpose assay that allowed us to infer a range of different genetic, epigenetic, and transcriptional tumor characteristics. Based on these data, we identified characteristic differences between primary and recurring tumors, links between DNA methylation and the tumor microenvironment, and an association of epigenetic tumor heterogeneity with patient survival. In summary, this study provides a resource for dissecting DNA methylation heterogeneity in genetically diverse and heterogeneous tumors, and it demonstrates the feasibility of integrating epigenomics, radiology, and digital pathology in a representative national cohort, leveraging samples and data collected as part of routine clinical practice.

cancer biology↗

Pooled CRISPR screening with single-cell transcriptome read-out

CRISPR-based genetic screens have revolutionized the search for new gene functions and biological mechanisms. However, widely used pooled screens are limited to simple read-outs of cell proliferation or the production of a selectable marker protein. Arrayed screens allow for more complex molecular read-outs such as transcriptome profiling, but they provide much lower throughput. Here we demonstrate CRISPR genome editing together with single-cell RNA sequencing as a new screening paradigm that combines key advantages of pooled and arrayed screens. This approach allowed us to link guide-RNA expression to the associated transcriptome responses in thousands of single cells using a straightforward and broadly applicable screening workflow.

genomics↗